{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:58:33Z","timestamp":1781074713814,"version":"3.54.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00228-026-04081-z","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T07:44:20Z","timestamp":1779781460000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of Ongericimab in patients with hypercholesterolemia: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"82","author":[{"given":"Ahmed L.","family":"Youseif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed F","family":"Younis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad W.","family":"Elmezayen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Eldahrawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha","family":"Hammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belal Mohamed","family":"Hamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr Reda","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa Ashraf","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar Abdulrahman","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya M.","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelaziz A.","family":"Awad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"issue":"1","key":"4081_CR1","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3390\/jcm12010363","volume":"12","author":"Z Du","year":"2023","unstructured":"Du Z, Qin Y (2023) Dyslipidemia and Cardiovascular Disease: Current Knowledge, Existing Challenges, and New Opportunities for Management Strategies. J Clin Med 12(1):363","journal-title":"J Clin Med"},{"key":"4081_CR2","unstructured":"Pappan N, Awosika AO, Rehman A Dyslipidemia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Jan 25]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK560891\/"},{"issue":"6","key":"4081_CR3","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.jacl.2015.08.006","volume":"9","author":"PM Moriarty","year":"2015","unstructured":"Moriarty PM, Thompson PD, Cannon CP, Guyton JR, Bergeron J, Zieve FJ et al (2015) Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial. J Clin Lipidol 9(6):758\u2013769","journal-title":"J Clin Lipidol"},{"issue":"11","key":"4081_CR4","doi-asserted-by":"publisher","first-page":"e028892","DOI":"10.1161\/JAHA.122.028892","volume":"12","author":"MJ Wilkinson","year":"2023","unstructured":"Wilkinson MJ, Lepor NE, Michos ED (2023) Evolving Management of Low-Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum. J Am Heart Assoc 12(11):e028892","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"4081_CR5","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1016\/j.numecd.2024.04.011","volume":"34","author":"W Zhao","year":"2024","unstructured":"Zhao W, Cheng Z, Ji X, Pei Z, Yang K, Huang Z et al (2024) Efficacy and safety of ongericimab given by prefilled syringe or autoinjector in primary hypercholesterolemia and mixed hyperlipidemia. Nutr Metab Cardiovasc Dis 34(9):2217\u20132225. https:\/\/doi.org\/10.1016\/j.numecd.2024.04.011","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"4081_CR6","unstructured":"Feingold KR et al Cholesterol-Lowering Drugs. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E (eds). Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000 [cited 2025 Jan 25]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK395573\/"},{"issue":"1","key":"4081_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-023-01690-3","volume":"9","author":"X Bao","year":"2024","unstructured":"Bao X, Liang Y, Chang H, Cai T, Feng B, Gordon K et al (2024) Targeting proprotein convertase subtilisin\/kexin type 9 (PCSK9): from bench to bedside. Sig Transduct Target Ther 9(1):1\u201349","journal-title":"Sig Transduct Target Ther"},{"issue":"21","key":"4081_CR8","doi-asserted-by":"publisher","first-page":"e026550","DOI":"10.1161\/JAHA.122.026550","volume":"12","author":"M Arca","year":"2023","unstructured":"Arca M, Celant S, Olimpieri PP, Colatrella A, Tomassini L, D\u2019Erasmo L et al (2023) Real-World Effectiveness of PCSK9 Inhibitors in Reducing LDL-C in Patients With Familial Hypercholesterolemia in Italy: A Retrospective Cohort Study Based on the AIFA Monitoring Registries. J Am Heart Assoc 12(21):e026550","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"4081_CR9","doi-asserted-by":"publisher","first-page":"e70061","DOI":"10.1111\/cts.70061","volume":"17","author":"J Jiang","year":"2024","unstructured":"Jiang J, Xu L, Chai L, Guan X, Zhang L, Liu H et al (2024) Clinical pharmacokinetics and pharmacodynamics of ongericimab: A potential long-acting PCSK9 monoclonal antibody in healthy subjects and patients with hypercholesterolemia: Randomized, double\u2010blind, placebo\u2010controlled phase Ia and Ib\/II studies. Clin Transl Sci 17(11):e70061","journal-title":"Clin Transl Sci"},{"issue":"11","key":"4081_CR10","doi-asserted-by":"publisher","first-page":"e033669","DOI":"10.1161\/JAHA.123.033669","volume":"4","author":"X Wang","year":"2024","unstructured":"Wang X, Qiu M, Cheng Z, Ji X, Chen J, Zhu H et al (2024) Efficacy and safety of ongericimab in Chinese patients with primary hypercholesterolemia and mixed dyslipidemia. J Am Heart Assoc 4(11):e033669","journal-title":"J Am Heart Assoc"},{"key":"4081_CR11","doi-asserted-by":"publisher","first-page":"120408","DOI":"10.1016\/j.atherosclerosis.2025.120408","volume":"407","author":"C Shao","year":"2025","unstructured":"Shao C, Zhang S, Cheng Z, Yang K, Wang G, Shi X et al (2025) Efficacy and safety of ongericimab in Chinese statin-intolerant patients with primary hypercholesterolemia or mixed dyslipidemia: a randomized, placebo-controlled phase 3 trial. Atherosclerosis 407:120408","journal-title":"Atherosclerosis"},{"key":"4081_CR12","doi-asserted-by":"publisher","first-page":"119120","DOI":"10.1016\/j.atherosclerosis.2025.119120","volume":"403","author":"J Lin","year":"2025","unstructured":"Lin J, Ji Y, Wang G, Ma X, Yao Z, Han X et al (2025) Efficacy and safety of ongericimab in Chinese patients with heterozygous familial hypercholesterolemia: A randomized, double-blind, placebo-controlled phase 3 trial. Atherosclerosis 403:119120","journal-title":"Atherosclerosis"},{"key":"4081_CR13","volume-title":"Cochrane handbook for systematic reviews of interventions","author":"J Chandler","year":"2019","unstructured":"Chandler J, Cumpston M, Li T, Page MJ, Welch V (2019) Cochrane handbook for systematic reviews of interventions. Wiley, Hoboken"},{"key":"4081_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1472-6947-7-16","volume":"7","author":"C Schardt","year":"2007","unstructured":"Schardt C, Adams MB, Owens T, Keitz S, Fontelo P (2007) Utilization of the PICO framework to improve searching PubMed for clinical questions. BMC Med Inf Decis Mak 7:16","journal-title":"BMC Med Inf Decis Mak"},{"key":"4081_CR15","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898","journal-title":"BMJ"},{"issue":"32","key":"4081_CR16","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","volume":"38","author":"BA Ference","year":"2017","unstructured":"Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E et al (2017) Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J 38(32):2459\u20132472","journal-title":"Eur Heart J"},{"issue":"1","key":"4081_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L et al (2020) 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 41(1):111\u2013188","journal-title":"Eur Heart J"},{"issue":"25","key":"4081_CR18","first-page":"e1082","volume":"139","author":"SM Grundy","year":"2018","unstructured":"Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS et al (2018) AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: A Report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines. Circulation 139(25):e1082\u2013e1143","journal-title":"Circulation"},{"issue":"25","key":"4081_CR19","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1016\/j.jacc.2012.03.007","volume":"19","author":"JM McKenney","year":"2012","unstructured":"McKenney JM, Koren MJ, Kereiakes DJ, Hanotin C, Ferrand AC, Stein EA (2012) Safety and efficacy of a monoclonal antibody to proprotein convertase subtilisin\/kexin type 9 serine protease, SAR236553\/REGN727, in patients with primary hypercholesterolemia receiving ongoing stable atorvastatin therapy. J Am Coll Cardiol 19(25):2344\u20132353","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"4081_CR20","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","volume":"376","author":"MS Sabatine","year":"2017","unstructured":"Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA et al (2017) Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease. N Engl J Med 376(18):1713\u20131722","journal-title":"N Engl J Med"},{"issue":"22","key":"4081_CR21","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","volume":"379","author":"GG Schwartz","year":"2018","unstructured":"Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R et al (2018) Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome. N Engl J Med 379(22):2097\u20132107","journal-title":"N Engl J Med"},{"issue":"16","key":"4081_CR22","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1056\/NEJMoa1501031","volume":"372","author":"JG Robinson","year":"2015","unstructured":"Robinson JG, Farnier M, Krempf M, Bergeron J, Luc G, Averna M et al (2015) Efficacy and safety of alirocumab in reducing lipids and cardiovascular events. N Engl J Med 372(16):1489\u20131499","journal-title":"N Engl J Med"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04081-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-026-04081-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04081-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:17:05Z","timestamp":1781072225000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-026-04081-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4081"],"URL":"https:\/\/doi.org\/10.1007\/s00228-026-04081-z","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"10 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"159"}}